ArticlePloS one2017

Novel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-γ production.

Pedro Henrique Papotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.